Opendata, web and dolomites

GDA in staphylococci

Gen Duplication and Amplification in Staphylococcal populations

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GDA in staphylococci project word cloud

Explore the words cloud of the GDA in staphylococci project. It provides you a very rough idea of what is the project "GDA in staphylococci" about.

exemplarily    biological    optimize    changing    acquire    experiments    acquiring    questions    gdas    extract    sequences    aureus    suffering    comprising    setups    cf    duplications    mechanisms    minor    additional    showed    hospital    sequence    causing    determinant    genomic    environmental    environment    accordingly    ca    techniques    detection    adaption    regions    antibiotics    natural    infections    material    resistances    experimental    copy    groundbreaking    species    scaffold    genome    frequency    clinical    pathogens    antibiotic    staphylococcus    horizontal    resistance    evolutionary    clinically    besides    dosage    data    unanswered    identification    technologies    ngs    cystic    sequencing    extend    amplifications    variation    adapt    almost    bacterial    387    gen    emrsa15    lung    valuable    organisms    usa300    gda    model    avenues    setting    genetic    fibrosis    difficulties    patients    pressure    bacteria    rapid    transfer    chronic    isolates    qpcr    infection    apparent    virulence    populations    validation    possess    readily    alter    putative    1200    regarding    exclusively    gene    coverage   

Project "GDA in staphylococci" data sheet

The following table provides information about the project.

Coordinator
EBERHARD KARLS UNIVERSITAET TUEBINGEN 

Organization address
address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074
website: www.uni-tuebingen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.imit.uni-tuebingen.de/arbeitsgruppen/infektionsbiologie/ag-heilbronner.html
 Total cost 171˙460 €
 EC max contribution 171˙460 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2018-03-02

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EBERHARD KARLS UNIVERSITAET TUEBINGEN DE (TUEBINGEN) coordinator 171˙460.00

Map

 Project objective

Bacterial pathogens possess the ability to adapt rapidly to changing environmental conditions which is especially apparent in the hospital setting where bacteria acquire antibiotic resistances readily. Besides well studied mechanisms such as horizontal gene transfer bacteria can alter the genetic material by acquiring gen duplications and amplifications (GDA). Exemplarily an improved gene dosage of a minor resistance determinant can lead to increased resistance to antibiotics. Due to the difficulties in their detection GDAs are almost exclusively studied in model organisms and neglected in natural populations of clinically relevant species such as Staphylococcus aureus. Accordingly many important questions about the frequency and clinical importance of GDAs remain unanswered. State of the art sequencing technologies enable the identification of GDAs by analysis of the coverage scaffold and groundbreaking experiments using 387 USA300 genome sequences showed promising results regarding putative copy number variation of virulence factors. We will extend the GDA analysis to ca. 1200 already available EMRSA15 sequences. This will enable a comprising analysis of gen copy number variation in clinical isolates and might allow identifying genomic regions under strong evolutionary pressure during infection. We will optimize experimental setups for the rapid validation of GDAs by qPCR and develop techniques to study the effects of GDAs in S. aureus. Furthermore we will sequence a selection ca. 70 S. aureus isolates causing chronic infections in patients suffering from cystic fibrosis (CF). This will enable us to optimize the detection of GDAs by NGS and will allow investigating the role of GDAs during adaption to the complex environment within the CF-lung. This project will show new avenues to extract additional valuable biological information from NGS data and will investigate the importance of GDAs during the adaption of S. aureus to the hospital setting and to the CF-lung.

 Publications

year authors and title journal last update
List of publications.
2016 Simon Heilbronner, Ian R. Monk, Jeremy R. Brozyna, David E. Heinrichs, Eric P. Skaar, Andreas Peschel, Timothy J. Foster
Competing for Iron: Duplication and Amplification of the isd Locus in Staphylococcus lugdunensis HKU09-01 Provides a Competitive Advantage to Overcome Nutritional Limitation
published pages: e1006246, ISSN: 1553-7404, DOI: 10.1371/journal.pgen.1006246
PLOS Genetics 12/8 2019-06-13

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GDA IN STAPHYLOCOCCI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GDA IN STAPHYLOCOCCI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

EngPTC2 (2019)

Exploring new technologies for the next generation pulse tube cryocooler below 2K

Read More  

MemoryAggregates (2020)

Mechanism of Whi3 Aggregation and its Age-dependent Malfunction

Read More  

pyrroQuin (2020)

Synthesis and Biological Evaluation of Pyrroquinoline Pseudo-Natural Products

Read More